Pamisel, Stock Price 21,500 Won.. Down -3.59% Compared to Previous Day

Pamiscell is trading at 21,500 KRW as of 1:32 PM on the 15th, down 3.59% from the previous day. This represents a 10.79% decline compared to May 29. Pamiscell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net sellers of 30,000 shares. Over the past five days, individual investors have been net buyers of 73,890 shares, while foreigners and institutions have been net sellers of 137,531 shares and net buyers of 84,595 shares, respectively.

On June 12, Pamiscell was a market topic with the news of "strength due to approval of phase 2 clinical trial for erectile dysfunction stem cell therapy."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.